Furthermore, IL-25 treatment could reduce partially the TNBS-colitis histologic scoring, suggesting that IL-25 may limit inflammation development by reducing IL-12 and IFNγ protein expression and cellular infiltration to the mucosa [76]. Here, IL25 is linked to colitis.